GlassScriptPhysician profile
Samuel B Aitchison
NPI 1750949368
$4,774.35
in general payments reported to CMS, 2019-2025
33 companies · $2,005 in 2025
The $2,005 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $215 · 2022: $323 · 2023: $1,094 · 2024: $1,136 · 2025: $2,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,235.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,014.53 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $784.97 | 2021-2025 | Ubrelvy, Linzess, Viberzi |
| Novo Nordisk INC | $464.09 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $325.55 | 2021-2025 | Mounjaro, Zepbound, Emgality |
| Glaxosmithkline, LLC. | $290.72 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $287.05 | 2021-2025 | Xifaxan, Trulance |
| Astellas Pharma US INC | $212.83 | 2022-2025 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $138.52 | 2021-2024 | Xarelto |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $118.03 | 2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $105.70 | 2023-2025 | |
| Dexcom, INC. | $102.05 | 2024-2025 | Dexcom G6 Transmitter |
| Csl Behring | $87.65 | 2021-2024 | Kcentra |
| Merck Sharp & Dohme LLC | $79.61 | 2021-2025 | Gardasil 9, Belsomra, Rotateq |
| Idorsia Pharmaceuticals US INC | $77.19 | 2022-2024 | Quviviq |
| Pfizer INC. | $71.69 | 2023-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $71.30 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $61.89 | 2024-2025 | Repatha, Otezla, Repatha |
| Vanda Pharmaceuticals INC. | $52.05 | 2025 | Fanapt |
| Insulet Corporation | $47.20 | 2025 | Omnipod |
| Genzyme Corporation | $43.09 | 2021 | |
| Corcept Therapeutics | $42.63 | 2025 | Korlym |
| Medtronic, INC. | $41.23 | 2025 | Intellis Adaptivestim |
| Lundbeck LLC | $41.00 | 2025 | Rexulti |
| Antares Pharma, INC. | $40.04 | 2025 | Xyosted |
| Abiomed | $29.26 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $28.60 | 2025 | Zoryve |
| Seqirus USA INC | $24.49 | 2025 | Fluad, Flucelvax |
| Globus Medical, INC. | $19.34 | 2025 | Senza |
| Eisai INC. | $18.10 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.01 | 2022 | |
| Sanofi Pasteur INC. | $13.81 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.34 | 2024 | Jardiance |
| Mylan Specialty L.P. | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Aitchison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.